What is the ROE (Return on Equity) of Epigenomics this year?
The ROE of Epigenomics this year is -1.18 undefined.
Epigenomics ROE 2024
Epigenomics ROE
-1.18
Ticker
ECX.DE
ISIN
DE000A3H2184
WKN
A3H218
In 2024, Epigenomics's return on equity (ROE) was -1.18, a 976.91% increase from the -0.11 ROE in the previous year.
Epigenomics Aktienanalyse
What does Epigenomics do?
Epigenomics AG is a German biotechnology company specializing in the development of diagnostics for the early detection of cancer. The company is headquartered in Berlin and was founded in 1997. Epigenomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Epigenomics's Return on Equity (ROE)
Epigenomics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Epigenomics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Epigenomics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Epigenomics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Epigenomics stock
How has the Return on Equity (ROE) of Epigenomics developed compared to the previous year?
The ROE of Epigenomics has increased by 976.91% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Epigenomics?
A high ROE indicates that Epigenomics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Epigenomics?
A low ROE can indicate that Epigenomics is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Epigenomics affect the company?
A change in ROE (Return on Equity) of Epigenomics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Epigenomics?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Epigenomics?
Some factors that can influence Epigenomics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Epigenomics pay?
Over the past 12 months, Epigenomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Epigenomics is expected to pay a dividend of 0 EUR.
What is the dividend yield of Epigenomics?
The current dividend yield of Epigenomics is .
When does Epigenomics pay dividends?
Epigenomics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Epigenomics?
Epigenomics paid dividends every year for the past 0 years.
What is the dividend of Epigenomics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Epigenomics located?
Epigenomics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Epigenomics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Epigenomics from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Epigenomics pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Epigenomics in the year 2023?
In the year 2023, Epigenomics distributed 0 EUR as dividends.
In which currency does Epigenomics pay out the dividend?
The dividends of Epigenomics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Epigenomics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Epigenomics
Our stock analysis for Epigenomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Epigenomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
